Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$316K Sell
6,070
-840
-12% -$47.3K 0.15% 130
2015
Q1
$399K Buy
6,910
+140
+2% +$8.03K 0.17% 127
2014
Q4
$362K Buy
6,770
+1,200
+22% +$67.1K 0.15% 131
2014
Q3
$320K Sell
5,570
-1,280
-19% -$78.5K 0.16% 125
2014
Q2
$458K Buy
6,850
+320
+5% +$21.7K 0.18% 119
2014
Q1
$436K Hold
6,530
0.18% 121
2013
Q4
$436K Buy
6,530
+800
+14% +$51.9K 0.18% 119
2013
Q3
$359K Buy
5,730
+480
+9% +$30.9K 0.16% 130
2013
Q2
$328K Buy
+5,250
New +$333K 0.19% 117

Other funds holding GSK

Semper Trust's GSK Position: Q2 2015 in Review

Semper Trust reduced its GSK (GSK) stake by 12% in Q2 2015, selling an estimated $47.3K and leaving 6,070 shares worth $316K. The position accounts for 0.15% of the portfolio, ranked #130.

Semper Trust first reported a position in GSK in Q2 2013 and has held it in 9 quarters since. The position peaked at $458K in Q2 2014. 719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

  • Semper Trust held 6,070 shares of GSK worth $316K as of Q2 2015.
  • Semper Trust sold 840 GSK shares in Q2 2015, an estimated $47.3K.
  • GSK made up 0.15% of Semper Trust's portfolio in Q2 2015, its #130 holding.
  • Semper Trust first reported a position in GSK in Q2 2013 and has held it in 9 quarters since.
  • Semper Trust's GSK position peaked at $458K in Q2 2014.
  • 719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Semper Trust's 13F filing for Q2 2015, filed 10 Aug 2015.